Back to announcement
20231129_SDPC_Laporan Informasi dan Fakta Material_31543688_lamp1.pdf
Other Text extracted SDPCSource file signed link, expires in 15 minutes
Extracted text 2
Page 1 OCR 0.912
MPI PT MILLENNIUM PHARMACON INTERNATIONAL Tbk No. 1 546/MPI/DIR/X1/2023 Jakarta, 29 November 2023 Lampiran : - Perihal : Laporan Informasi atau Fakta Material Yth. Kepala Eksekutif Pengawas Pasar Modal Otoritas Jasa Keuangan Gedung Soemitro Djojohadikusumo Jalan Lapangan Banteng Timur 2-4 Jakarta 10710 Sehubungan dengan Peraturan Otoritas Jasa Keuangan (OJK) no: 31/POJK.04/2015 tanggal 16 Desember 2015 tentang Keterbukaan Informasi atas Fakta Material oleh Emiten atau Perusahaan Publik dan Surat Keputusan Direksi PT Bursa Efek Indonesia No. Kep-00066/BEI/09-2022 tanggal 30 September 2022 perihal Perubahan Peraturan Nomor I-E tentang Kewajiban Penyampaian Informasi, dengan ini kami menyampaikan Laporan Informasi atau Fakta Material sebagai berikut : In reference to Otoritas Jasa Keuangan (OJK) Reguletion No.: 31/POJK.04/2015 dated 16 December 2015 regarding Disclosure Information of Material Fact by Issuer or Public Company and PT Bursa Efek Indonesia's Board of Director Decree No. Kep-00066/BEN09-2022 dated 30 September 2022 regarding to the Changes on the Provision No. I-E regarding Obligation of Information Submision, we hereby disclose the information and Material Fact as follow: Nama Emiten atau Perusahaan Publik//ssuer: PT Millennium Pharmacon International Tbk (“Perseroan”) Bidang Usaha/Scope of Business : Distribusi produk farmasi, suplemen makanan dan alat kesehatan Telepon/Phone 1 (021) 2708 5961, (021) 2708 5964 Faksimili/Facsimile 1 (021)2708 5958 Alamat surat elektronik/e-mail : investor.relation@mpi-pharmaniaga.co.id (1 ( Tanggal kejadian Date Event | 27 November 2023 November 27", 2023 l | 2 | Jenis Informasi atau Fakta Material Type of Information or Material Facts | Penandatanganan Perubahan dan Penegasan | Signing of Amendments and Reaffirmation of | Kembali Perjanjian Kredit Credit Agreements 3 | Uraian Informasi atau Fakta Material Description of Information or Material Facts a) Pihak-pihak yang melakukan perjanjian: | a) Parties to the agreement : Company and PT Perseroan dan PT Bank UOB Indonesia, Bank UOB Indonesia, b) Bank telah menyetujui perpanjangan | b) The Bank has approved the renewal of the | fasilitas kredit dengan total limit sejumlah credit facilities with total limit facility | Rp370 Miliar kepada Perseroan: amounted to IDR370 billion to the company: | Crown Bungur Arteri 2-4th Floors RS ' Jl. Sultan Iskandar Muda No. 18, Jakarta 12240, Indonesia TRACE | socne ) - Phone : #6221 27085961 Fax : #6221 27085958 MEMBER Ka
Page 2 OCR 0.924
MPI PT MILLENNIUM PHARMACON INTERNATIONAL Tbk |” Te) Perubahan Jangka waktu perjanjian telah disetujui diperpanjang sampai dengan tanggal 29 Januari 2025. c) Changes the Agreement Period has been approved to be extended until January 29th, 2025. 4 | Dampak kejadian, informasi atau fakta | | material tersebut terhada iatan operasional, hukum, kondisi keuangan, atau kelangsungan usaha Emiten atau Perusahaan Publik Fasilitas Kredit ini menunjang kegiatan usaha perseroan. Impact for such information or material fact towards operational activity, legal, financial condition or business continuity of Issuer or | Public Company | This Credit Facility supports the company's business activities. 5 | Keterangan lain-lain Tidak ada Other Information None Hormat kami, PT Millennium Pharmacon International Tbk Nama: Ahmad bin|Abu Bakar Jabatan: Direktur Utama Tembusan: PT Bursa Efek Indonesia u.p. Yth. Direksi Crown Bungur Arteri 2-4th Floors Jl. Sultan Iskandar Muda No. 18, Jakarta 12240, Indonesia Phone : #6221 27085961 Fax : 6221 27085958 MEMBER
Names mentioned 0 people and organisations named in the text · linked when the evidence is strong
The name pass has not read this document yet.
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.